Omron (OTCMKTS:OMRNY) Stock Falls 7.4% – What’s Next?

Omron Corp. (OTCMKTS:OMRNY)’s share price fell 7.4% on Friday. The company traded as low as $36.78 and last traded at $36.78. Approximately 1,132 shares were traded during trading, a decline of 98% from the average daily volume of 46,236 shares. The stock had previously closed at $39.74.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, August 10th. Two research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Omron Stock Down 3.0%

The company has a market cap of $7.54 billion, a PE ratio of 34.83, a P/E/G ratio of 0.78 and a beta of 1.22. The company’s 50 day moving average is $40.47 and its 200 day moving average is $36.56. The company has a current ratio of 1.93, a quick ratio of 1.49 and a debt-to-equity ratio of 0.09.

Institutional Investors Weigh In On Omron

An institutional investor recently raised its stake in Omron stock. GAMMA Investing LLC boosted its stake in shares of Omron Corp. (OTCMKTS:OMRNY) by 12.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,536 shares of the company’s stock after buying an additional 382 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $144,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 1.09% of the company’s stock.

Omron Company Profile

Omron Corporation is a Japan-based technology company that develops automation, sensing, control and healthcare solutions. Its products include industrial sensors, controllers, machine-vision and inspection systems, safety equipment, robotics and other factory-automation technologies used to improve manufacturing productivity and quality.

Through its healthcare business, Omron provides blood-pressure monitors, electrocardiographs, nebulizers, body-composition monitors and related digital health services for consumers and medical professionals.